REFERENCES
- Hindmarsh JT. Microalbuminuria. Clin Lab Med. 1988; 8: 611–616
- Chiarelli F, Verrotti A, Mohn A, Morgese G. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: Therapeutic implications. Ann Med. 1997; 29: 439–445
- Mogensen CE. Preventing end-stage renal disease. Diabet Med 1998; 15(Suppl. 4)S51–S56
- Schwab SJ, Dunn FL, Feinglos MN. Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis. Diabetes Care. 1992; 15: 1581–1584
- Kin PT, Wee A, Dan L, Guo J. Diagnostic test—O & G / Pregnancy. MIMS Medex 971st, PT Kin, A Wee, L Dan, J Guo. Medi & Media, Bangkok 1997; 145–146
- Frenkell AI, Nemzer S, Pister I, Soussan L, Harris T, Sun Y, Rafailovich MH. Size-controlled synthesis and characterization of thiol-stabilized gold nanoparticles. J Chem Phys. 2005; 123: 184701
- Airoldi G, Campanini M. Microalbuminuria: Theoretical bases and new applications. Recenti Prog Med. 1993; 84: 210–224
- Service RF. Nanotechnology: Color-changing nanoparticles offer a golden ruler for molecules. Science. 2005; 308: 1099